Please Wait...

Clinical Adjudication

Bioclinica's Clinical Adjudication Service provides a key role in determining the efficacy and safety endpoints needed to analyze clinical trial outcomes, which are necessary in determining clinical trial success.

Clinical Adjudication

Flexible modeling of any adjudication pathway coupled with transparency of workflow status along with immediate data accessibility

Determining acceptable safety results during a clinical trial by way of independent electronic event adjudication committees is the most efficient process to assist sponsors in reducing costs, increasing quality, and eliminating clinical bias. Bioclinica's Clinical Adjudication Service provides sponsors with the ability to electronically manage safety endpoints from notification of an endpoint at a clinical trial site through central review by therapeutic experts. This allows for an efficient and streamlined process that ensures high quality and timely results. Therapeutic expertise backed by automated technology enables continuous adjudication with real-time results.

Bioclinica's Clinical Adjudication Service is completely customizable in order to best meet a sponsor's adjudication requirements. Our vast library of eCRF logic and safety and efficacy parameters is designed to meet adjudicator, sponsor, and regulatory data delivery compliance needs.

Bioclinica's Clinical Adjudication Service benefits to a sponsor:

THOUGHT LEADERSHIP

  • Comprehensive medical expertise across all therapeutic areas
  • Uniform event definition across all event types
  • Ensures site compliance with event reporting
  • Efficient and automated adjudication workflows
  • Real-time access to data enabling faster adjudication
  • Ease of electronic process reducing manual errors and costs
  • Real-time online access to adjudication results and data reports
  • Data visualization of research site, user and adjudicator performance metrics
  • Integrated global language translation and redaction services
  • 24/7/365 live support
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Kevin Bishop, named a 'Top Innovator' in #clinicaltrials by @CenterWatch See how we're reducing risk to the clinic… https://t.co/rXBGvIh9Wr
bioclinica (Yesterday)
RT @CenterWatch: Congratulations to all our #2018TopInovators! Read about the innovations in the #CWMonthly special edition, https://t.co/Y…
bioclinica (5 days ago)
RT @CenterWatch: .@Pfizer demonstrates leadership in #clinicaltrial innovation with two spots on the @CenterWatch #2018TopInnovators, https…
bioclinica (5 days ago)
RT @jheanne: I just contributed towards 'Joby' on https://t.co/EHt69JFLZ9 Best wishes to Joby and all our @Bioclinica team members! @Oxfam…
bioclinica (5 days ago)
RT @FDA_Drug_Info: Read our report “Advancing Health through Innovation: New Drug Approvals and Other Drug Therapy Advances of 2017” to lea…
bioclinica (5 days ago)
RT @CDISC: Join us for CDISC's first public webinar of 2018 - Controlled Terminology Quarterly Updates https://t.co/2EbR3X9TsG
bioclinica (5 days ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen